Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Poly(L-lactic acid) (PLLA) is a biocompatible, biodegradable synthetic polymer of L-lactic acid widely used in medicine as an injectable bio-stimulatory dermal filler. Its primary mechanism is to stimulate collagen production by inducing a mild inflammatory response that leads to extracellular collagen deposition. PLLA is FDA-approved for the treatment of facial lipoatrophy associated with HIV and for correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles. It has also been used off-label for tissue augmentation, body plasticity, correction of skin laxity in various regions (face, neck, chest, buttocks), and general facial rejuvenation. The effects are gradual and long-lasting due to slow degradation kinetics[1][2][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on poly(L-lactic acid).